Boston, MA - Low-molecular-weight heparins (LMWHs) could potentially replace unfractionated heparin as the antithrombin of choice across the spectrum of acute coronary syndromes. In addition, they ...
Events picked up with the Fourth Universal Definition of MI were tied to higher mortality, emphasizing the role of ancillary ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Antiplatelet therapy with ticagrelor after primary PCI ...
The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer-reviewed. Various P2Y 12 inhibitors have different efficacies and bleeding risks, and ...
PARSIPPANY, N.J. and INDIANAPOLIS, March 29, 2011 /PRNewswire/ -- Oral antiplatelet therapy Effient® (prasugrel) has been added to the updated clinical practice guidelines as a Class I recommended ...
Background Prehospital delays remain critical barriers to timely acute coronary syndrome (ACS) care, particularly for ...
SAN DIEGO — In a secondary analysis from the SECURE-PCI trial, a periprocedural loading dose of atorvastatin reduced 30-day MACE rates in patients with STEMI undergoing PCI, researchers reported at ...
MIAMI, Oct. 23, 2012 /PRNewswire/ -- Daiichi Sankyo, Inc. and Eli Lilly and Company (NYSE: LLY) today announced new results of two retrospective, observational, comparative effectiveness studies of ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHILADELPHIA -- ...
Antithrombotic therapy during percutaneous coronary intervention for ST-segment elevation myocardial infarction has evolved substantially over the past 15 years. With the results of the ATOLL trial, ...
SAN DIEGO, CA—Prior data from the SECURE-PCI study hinted that statin preloading might benefit patients with ACS undergoing PCI, but a new analysis suggests that the benefit might be particularly ...